Hologic (HOLX) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Canaccord Genuity Raises Price Target on Hologic (HOLX) Following 3Q Beat and FY15 Guidance Raise
July 30, 2015 10:49 AM EDTCanaccord Genuity reiterated a Buy rating on Hologic (NASDAQ: HOLX), and raised the price target to $45.00 (from $40.00), following FQ3 results. Adjusted EPS of $0.43 beat the Street's $0.39 estimate. Revenues of $693.9M beat consensus estimates of $654M. HOLX raised FY'15 rev guidance by $82M at the midpoint to $2,687-2,697M, from $2,600-2,620M, and... More
